BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).
Dr. Cook answers the question: 'Pros of Giving Insulin By Pen/Syringe?' — -- Question:What are the pros and cons of giving insulin by syringe and by pen? Answer:Well the pen-versus-syringe ...
Insulin is generally administered either by the patient himself or by some member of his family, a neighbor, a practical nurse or a registered nurse. Only occasionally is it given by the physician.
Barriers to adherence include “complicated regimens, fear of injection pain, social embarrassment, lack of confidence about self-injection, perception of injectable therapy as inconvenient, and belief ...
The US Food and Drug Administration has approved a dedicated syringe (Becton Dickinson) for administering Humulin R U-500 insulin (Lilly). Humulin R U-500 is indicated for blood glucose control in ...
The FDA approved a dedicated syringe for the administration of Humulin R U-500 insulin, eliminating the need for dose conversions for patients who used U-100 or tuberculin syringes. The dedicated ...
Nipro Medical Corporation has initiated a nationwide recall of GlucoPro insulin syringes because the defective products may contain needles that can detach from the syringe. If the needle becomes ...
People with diabetes who use ReliOn insulin syringes should check their syringe package because of an important recall. Tyco Healthcare Group (Covidien) is recalling 4,710 boxes of the syringes - with ...
Qualitest Pharmaceuticals is recalling two lots of Accusure insulin syringes because the products' needles can detach from the syringes. When the needle becomes detached from the syringe during use, ...
January 25, 2010 — A voluntary nationwide recall of all GlucoPro Insulin Syringes (Nipro Medical Corporation) is underway, according to a US Food and Drug Administration (FDA) notification to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results